Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Nov 9;16(11):e0259533. doi: 10.1371/journal.pone.0259533

A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Covid?

Sally Fowler-Davis 1,*, Katharine Platts 1, Michael Thelwell 1, Amie Woodward 2, Deborah Harrop 1
Editor: Sinan Kardeş3
PMCID: PMC8577752  PMID: 34752489

Abstract

Objectives

Fatigue syndromes have been widely observed following post-viral infection and are being recognised because of Covid19. Interventions used to treat and manage fatigue have been widely researched and this study aims to synthesise the literature associated with fatigue interventions to investigate the outcomes that may be applicable to ‘long Covid’.

Method

The study was registered with PROSPERO (CRD42020214209) in October 2020 and five electronic databases were searched. Papers were screened, critically appraised and data extracted from studies that reported outcomes of fatigue interventions for post-viral syndromes. The narrative synthesis includes statistical analysis associated with effectiveness and then identifies the characteristics of the interventions, including identification of transferable learning for the treatment of fatigue in long Covid. An expert panel supported critical appraisal and data synthesis.

Results

Over 7,000 research papers revealed a diverse range of interventions and fatigue outcome measures. Forty papers were selected for data extraction after final screening. The effectiveness of all interventions was assessed according to mean differences (MD) in measured fatigue severity between each experimental group and a control following the intervention, as well as standardised mean differences as an overall measure of effect size. Analyses identified a range of effects–from most effective MD -39.0 [95% CI -51.8 to -26.2] to least effective MD 42.28 [95% CI 33.23 to 51.34]–across a range of interventions implemented with people suffering varying levels of fatigue severity. Interventions were multimodal with a range of supportive therapeutic methods and varied in intensity and requirements of the participants. Those in western medical systems tended to be based on self- management and education principles (i.e., group cognitive behavioural therapy (CBT).

Conclusion

Findings suggest that the research is highly focussed on a narrow participant demographic and relatively few methods are effective in managing fatigue symptoms. Selected literature reported complex interventions using self-rating fatigue scales that report effect. Synthesis suggests that long Covid fatigue management may be beneficial when a) physical and psychological support, is delivered in groups where people can plan their functional response to fatigue; and b) where strengthening rather than endurance is used to prevent deconditioning; and c) where fatigue is regarded in the context of an individual’s lifestyle and home-based activities are used.

Introduction

Fatigue is a common problem resulting from a range of conditions including cancer, multiple sclerosis (MS), and post-viral syndromes. Fatigue symptoms are always limiting but if there is an identifiable cause (e.g., poor sleep patterns) and lasts for less than three months, can be managed by resolving the underlying cause [1]. Chronic fatigue is experienced with a greater intensity and longer duration, causing severe disruption to daily life, functional activity and quality of life [2, 3]. The debilitating and prolonged nature of fatigue can pose significant economic consequences for society and significant anxiety and depression for the individual.

Fatigue management in practice has been recommended for cancer [4] and multiple-sclerosis [5], in rheumatoid arthritis [6, 7] and in a workplace context [8] and is most notably the core component of treatment for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME) and fibromyalgia. Complex interventions can include exercise, psychological/behavioural, dietary and ‘alternative’ medicine including acupuncture and yoga. Interventions for fatigue can be home-based or undertaken in a clinical setting and studies of multi-modal interventions, i.e. crossover trials or studies involving a pharma component, as a complex intervention, have proliferated in recent years and are the subject of several Cochrane Reviews [9, 10].

In 2007, the National Institute of Care Excellence (NICE) identified the effectiveness of rest and management approaches for fatigue experience in the context of CFS/ME [11] recommending cognitive behavioural therapy (CBT) and graded exercise therapy (GET). These methods were substantiated by a programme of research focussed on results of evidence from several randomised controlled trials in the UK [1214]. However, new guidance drafted in 2020 and currently under further development (NICE Guidance: GID-NG10091) [15] cited a “lack of evidence for the effectiveness of these interventions” based on a wide-spread reaction from patients who recognised the potentially harmful effects of over-generalised advice on exercise. NICE recommendations were deemed to be problematic because the focus is exclusively on Grading of Recommendations Assessment, Development and Evaluation (GRADE) standards to evaluate the evidence. Further work to identify fatigue interventions for use in holistic rehabilitation therefore remains an important challenge [16].

The recent Covid 19 pandemic has resulted in the early reporting of the later effects of the viral infection that can be characterised as a post-viral syndrome [17]. People with post-Covid Syndrome (popularly known as ‘long Covid’) suffers can experience a long-term state of chronic fatigue characterised by post-exertional exhaustion [18]. This appears to have a common aetiology to CFS/ME type fatigue, but long Covid fatigue co-exist with other symptoms including shortness of breath and associated anxiety [19]. The persistence of fatigue, at around three months post-infection [20] appears to be associated with moderate to severe depression [21] and a worsened quality of life [19]. It appears that hospitalisation is not necessarily predictive of long Covid, and Covid-19 not predictive of outcomes [22] and there is a non-specific sequalae of long Covid [23].

Although a substantial body of studies on short-term outcomes of Covid-19 inpatients has already been produced, the literature associated with long-term outcomes is limited [24]. Whilst many individuals recover and have resumed their usual functional activity, a residual number of people require follow up and a small literature is building around the response from health and care services, including a call for an integrated team-based response [25]. With the development of NHS long Covid Clinics [26] there was an early recognition that post-viral fatigue was a common symptom, with patients reporting significant functional limitations for many months after their initial infection [27]. The World Health Organisation (WHO) has called for recognition, research, and rehabilitation in line with the growing demand for treatment and management [28].

The aim of this study is to systematically review the literature associated with fatigue management interventions, their characteristics and outcomes, and to identify the characteristics of treatments that may be useful in the management of long Covid.

Materials and methods

The present review was conducted in accordance with preferred reporting for systematic review guidelines (PRISMA). A review protocol was developed and registered with the NIHR International Prospective Register of Systematic Reviews (PROSPERO), registration number CRD42020214209.

Eligibility criteria

A Population, Intervention, Comparator, Outcome, Study-type (PICOS) framework was used to define the eligibility criteria. The population of interest was characterised as people of any age across all countries and of all ethnicities, based on post-viral or bacterial infection syndromes that manifest as post-viral fatigue. Those undergoing radiation or chemotherapy, or those with fatigue caused by auto-immune response following cancer or MS were excluded. Those with physiological or acute fatigue associated with fever, infection, sleep disturbances, pregnancy, extreme physical activity (excessive energy consumption), work-related burnout, or a primary depression/psychosis diagnosis were excluded on the basis that fatigue was not experienced because of past viral infection.

Fatigue management or energy conservation interventions were associated with exercise, psychological, behavioural, dietary, diet supplements or complementary/alternative medicine (CAM) interventions. Those included had reported outcome measures and were undertaken in a non-inpatient setting. Pharmacological-only interventions were excluded. Mixed interventions and studies involving a pharmacological component were included only when fatigue outcome measurement data could be extracted.

The principal outcome of interest was fatigue, and only studies that assessed fatigue as a distinct and separate outcome attributable to a fatigue management intervention were selected. Both physical and mental fatigue were included in the definition as measured by a recognised fatigue research measure. Secondary outcomes of interest were acceptability of intervention to users, mechanisms of action, and intervention characteristics including duration, intervention type, timing of intervention, mode of delivery and by whom (professional/peer), group nature, and infrastructure e.g., technology assisted.

Primary research from the period 2002–2020 was deemed eligible for inclusion, to allow for literature related to the SARS (SARS-CoV-1) epidemic of 2002–2004 to be captured. Qualitative, quantitative and mixed-methods designs were included. Studies comparing effectiveness of interventions against usual care groups or non-exposed control groups were selected, while uncontrolled trials were excluded. Reviews and case studies were excluded. Non-English language literature was excluded due to the financial costs associated with translation.

Information sources

A search of online databases (CENTRAL, CINAHL, MEDLINE (EBSCO), ProQuest (APA PsycINFO), SCOPUS, SportDISCUS) was conducted to identify relevant literature in October 2020. Where documents were not available directly from the publisher’s website, access was requested via Sheffield Hallam University document supply services. The International Clinical Trials Registry Platform (World Health Organization) was searched, as well as the UK Clinical Trials Gateway (NHS, National Institute for Health Research).

Search strategy

The search strategy comprised two facets: terms to describe fatigue or causes of post-viral fatigue; combined with terms to describe types of interventions, e.g., clinical trials. The Boolean operators AND and OR were used to combine search terms. Controlled vocabulary terms were used where available, and when supported by the database. Refer to S1 File for a copy of the search strategy as written up for MEDLINE (EBSCO) and ProQuest (APA PsycInfo). The search strategy was adapted for other databases.

Study selection and quality appraisal

Following the removal of duplicates, the titles and abstracts of all studies yielded from the literature searches were screened by a review author to assess suitability for inclusion against PICOS criteria. A second reviewer independently screened 10% of the studies by title and abstract. Papers selected for full-text screening were retrieved and independently assessed for eligibility by review authors (MT, KP and SFD), with 10% of the papers screened by a second review author (DH) to check for conformity of selection and to quality assess the level of agreement between reviewers. Disagreements in screening decisions were resolved through discussions within the research team. All papers selected at final full text screening stage were subject to a preliminary quality appraisal using the Mixed Methods Appraisal Tool (MMAT) (Table 1). For each study, an overall quality score was calculated based on the number of MMAT criteria that each study satisfied. Papers were not automatically excluded based on outcomes from the MMAT and additional quality appraisal was undertaken continuously by review authors. Trustworthiness of the selected papers was undertaken in consultation with the expert panel who shared their thoughtful and informative but necessarily more subjective views of the literature, and a mechanistic approach was not used [29].

Table 1. Overview of studies selected for review.

Lead author (Year) Title Intervention groups (n) Participants Setting Study design Intervention duration MMAT Quality Score
Age: Mean (SD)
(A-Z)
Sex: Female / Male (%)
Clark (2017) Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial SMC (102) 38.4 (11.9) years Secondary care / Specialist clinic Open-label, pragmatic RCT 8 weeks 5
GET & SMC (97)
79% / 21%
Dailey (2013) Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia No TENS (41) 49.2 (12) years Not stated Randomised, placebo-controlled cross-over 3 weeks 5
Active TENS (41) 98% / 2%
Placebo TENS (41)
Demirbag (2012) The effects of sleep and touch therapy on symptoms of fibromyalgia and depression Control (54) 42.5 (11.8) years Community / Clinic Randomised comparison study with control 6 weeks 3
TMA (54)
SMA (54) 110% / 0%
El Mokadem (2020) Three principles/innate health: The efficacy of psycho-spiritual mental health education for people with chronic fatigue syndrome Waiting list (11) 42.9 (10.5) (range: 19–66) years Not stated Randomised trial with waitlist control 8 weeks 4
Three Principles/Innate Health (11)
86% / 14%
Ericsson (2016) Resistance exercise improves physical fatigue in women with fibromyalgia: a randomized controlled trial Relaxation (63) 51.4 (9.4) years Community / Clinic Multicentre RCT 15 weeks 3
Group-based GET (67) 100% / 0%
Fernie (2016) Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome CBT (116) 40.8 (12.5) (range: 18–75) years Secondary care / outpatient Comparison of CBT & GET in practice 4 months 3
GET (55)
Fitzgibbon (2018) Evidence for the improvement of fatigue in fibromyalgia: a 4-week left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation randomized-controlled trial Sham rTMS (12) 45.6 (12.8) years Secondary care / Lab-based Randomised, double-blind placebo controlled 4 weeks 5
rTMS (14)
92% / 8%
Friedberg (2016) Efficacy of two delivery modes of behavioural self-management in severe chronic fatigue syndrome SMC (46) 48.4 (11.5) years Primary care / home-based Randomised comparison 3 months 4
Self-management & web diaries (39)
88% / 12%
Self-management & paper diaries (39)
Hansen (2013) Heart rate variability and fatigue in patients with chronic fatigue syndrome after a comprehensive cognitive behaviour group therapy program Healthy controls (21) 41.6 (range: 29–67) years Not stated Comparison (healthy controls vs. CFS patients) 4 days 4
CBT / GET / Group therapy (19) 100% / 0%
Heald (2019) Service based comparison of group cognitive behaviour therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions Waiting list (28) 43.1 (13.2) years Primary care / specialist clinic Repeated measures–individuals act as own control 8 weeks 4
Group CBT (28)
61% / 39%
Jason (2010) Provision of social support to individuals with chronic fatigue syndrome Waiting list (15) 57.6 (13) years Primary care / home-based Randomised trial with waitlist control 4 months 4
Social support (15) 83% / 17%
Keijmel (2017) Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): a Randomized Controlled Trial Placebo (52) 43.8 (12.1) years Secondary care / Lab-based RCT 24 weeks 4
Doxycycline (52)
CBT (50) 48% / 52%
Kim (2013) Indirect moxibustion (CV4 and CV8) ameliorates chronic fatigue: a randomized, double-blind, controlled study Sham Moxibustion (20) Median: 44 (range: 32–63) years Lab-based Double-blinded RCT 4 weeks 4
Moxibustion (25) 78% / 22%
Kim (2015) Acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue: a multicenter, nonblinded, randomized controlled trial SMC (50) 42.2 (11.7) years Secondary care RCT 4 weeks 4
Acupuncture & SMC (49)
65% / 35%
Sa-am Acupuncture & SMC (51)
Lee (2015) The effect of oriental medicine music therapy on idiopathic chronic fatigue Waiting list (15) 44.9 (12.4) years Secondary care / outpatient Randomised trial with waitlist control 2 weeks 4
Oriental medicine music therapy (15)
90% / 10%
Maddali (2016) Efficacy of rehabilitation with Tai Ji Quan in an Italian cohort of patients with Fibromyalgia Syndrome Educational course (22) 52.2 (12.2) years Primary care / home-based Randomised comparison 16 weeks 4
Tai Ji Quan (22)
Marques (2015) Effects of a Self-regulation Based Physical Activity Program (The ’4-STEPS’) for Unexplained Chronic Fatigue: a Randomized Controlled Trial SMC (46) 48.1 (11) years Community / home-based Multicentre RCT 12 weeks 3
Self-regulation Based Physical Activity (45) 98% / 2%
Marques (2017) Efficacy of a randomized controlled self-regulation based physical activity intervention for chronic fatigue: mediation effects of physical activity progress and self-regulation skills SMC (46) 48.1 (11) years Primary care / home-based Multicentre RCT 12 weeks 3
Self-regulation Based Physical Activity (45) 98% / 2%
Mist (2018) Randomized Controlled Trial of Acupuncture for Women with Fibromyalgia: group Acupuncture with Traditional Chinese Medicine Diagnosis-Based Point Selection Group Education (14) 54 (12.4) years Community / Specialist clinic Random allocation / repeated measures 10 weeks 4
100% / 0%
Group Acupuncture (16)
Ng (2013) Acupuncture for chronic fatigue syndrome: a randomized, sham-controlled trial with single-blinded design Sham Acupuncture (49) 40.9 (6.6) years Lab-based Single-blinded RCT 4 weeks 3
69% / 31%
Acupuncture (50)
O’Dowd (2006) Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme SMC (51) 41.1 (11.9) years Secondary care / outpatient Double-blind RCT 16 weeks 4
CBT (52)
GET (50) 66% / 33%
Oka (2014) Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial Pharma (15) 38.6 (12.6) years Community / Clinic RCT 2 months 4
Yoga & Pharma (15)
80% / 20%
Perrin (2011) Muscle fatigue in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and its response to a manual therapeutic approach: A pilot study Healthy controls (9) 35.8 (range: 20–55) years Lab-based Comparison–osteopathy vs self-selected treatment vs healthy control 12 months 3
Osteopathic treatment (9)
Any treatment (9) 44% / 56%
Powell (2004) Patient education to encourage graded exercise in chronic fatigue syndrome: 2-year follow-up of randomised controlled trial SMC (34) 33.2 (10.3) years Outpatient / home-based RCT 12 months 3
GET:
Min. intervention (37) 75% / 25%
Telephone intervention (39)
Max. intervention (33)
Racine (2019) Operant Learning Versus Energy Conservation Activity Pacing Treatments in a Sample of Patients With Fibromyalgia Syndrome: a Pilot Randomized Controlled Trial Control (43) No details Community / Clinic RCT 10 weeks 3
Operant learning (17)
Energy conservation activity pacing (24)
Raijmakers (2019) Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study Placebo (52) 43.8 (12.1) years Secondary care / outpatient RCT 24 weeks 4
Doxycycline (52)
CBT (50) 48% / 52%
Ridsdale (2012) The effect of counselling, graded exercise and usual care for people with chronic fatigue in primary care: a randomized trial SMC & CBT booklet (75) 39.8 (range: 34–46) years Primary care / home-based RCT 12 months 5
GET (71) 78% / 22%
Counselling (76)
Sharpe (2015) Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial SMC (115) 38 (12) years Primary care / Community Multicentre randomised trial 6 months 3
APT & SMC (120) 77% / 23%
CBT & SMC (119)
GET & SMC (127)
Shu (2016) Acupuncture and Moxibustion have Different Effects on Fatigue by Regulating the Autonomic Nervous System: a Pilot Controlled Clinical Trial Healthy controls (15) 37.1 (14.3) years Lab-based RCT 3 weeks 3
Acupuncture (15) 73% / 27%
Moxibustion (15)
Stubhaug (2008) Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial Placebo (24) 46.32 (8.75) years Not stated RCT 24 weeks 4
Mirtazapine (25)
CBT (23) 82% / 18%
Tummers (2010) Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial SMC (85) 38.1 (10.3) years Outpatient / home-based Randomised non-inferiority study 6 months 2
Self-instruction & CBT (84)
79% / 21%
UÄŸurlu (2017) The effects of acupuncture versus sham acupuncture in the treatment of fibromyalgia: a randomized controlled clinical trial Sham Acupuncture (25) 45.4 (8.2) years Community / Specialist clinic RCT 5 weeks 4
100% / 0%
Acupuncture (25)
Van Hoof (2003) Hyperbaric Therapy in Chronic Fatigue Syndrome HBOT: 42 (13) years Lab-based Randomised sampling 1 week 5
Healthy controls (13) 66% / 34%
Infection (13)
Vos-Vromans (2016) Multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial CBT (60) 40.3 (11.1) years Community Multicentre RCT 10 weeks 3
Multidisciplinary rehabilitation treatment (62)
80% / 20%
Wearden (2010) Nurse led, home-based self-help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial SMC (100) 44.6 (11.4) years Primary care / home-based Single-blind RCT 18 weeks 4
Pragmatic rehab (95) 78% / 22%
Supportive listening (101)
Weatherley-Jones (2004) A randomized, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome Placebo (50) 38.9 (10.8) years Community / Clinic Triple-blind RCT 6 months 4
Homeopathic medication (53)
59% / 41%
White (2011) Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial SMC (160) 38 (12) years Secondary care Multicentre randomised trial 24 weeks 4
APT & SMC (159) 77% / 23%
CBT & SMC (161)
GET & SMC (160)
Wiborg (2015) Randomised controlled trial of cognitive behaviour therapy delivered in groups of patients with chronic fatigue syndrome Waiting list (68) 37.9 (11.3) years Secondary care / outpatient RCT 6 months 5
CBT:
Large group (68)
Small group (68) 77% / 23%
Windhorst (2017) Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: an exploratory pilot study Biofeedback (13) 50.7 (9.3) years Secondary care / outpatient Randomised study 8 weeks 5
GET (11) 100% / 0%
Wu (2020) Observation on therapeutic efficacy of tuina plus cupping for chronic fatigue syndrome Ginseng lozenges (50) 40.1 (5.1) years Community / Specialist clinic RCT 16 weeks 4
63% / 37%
Tuina & Cupping (50)

Cognitive behavioural therapy (CBT); Chronic Fatigue Syndrome (CFS); Graded Exercise Therapy (GET); Randomised controlled trial (RCT); Adaptive Pacing Therapy (APT); Standard Medical Care (SMC); Transcutaneous electrical nerve stimulation (TENS); Hyperbaric oxygen therapy (HBOT); Touch, Music & Aroma (TMA); Sleep, Music & Aroma (SMA); Repetitive transcranial magnetic stimulation (rTMS); Standard deviation (SD).

Data extraction

Papers were selected for final inclusion where they met all criteria and data was harvested from the selected papers and collated in an a priori data extraction form created for the purposes of the review. The data extraction exercise was piloted by all review authors with three authors undertaking the data extraction exercise.

Extracted data included: bibliographic information, country of study, hypotheses/research question, intervention setting, study design, recruitment and sampling procedures, participant data (age, gender, ethnicity, diagnoses), intervention data (mechanism of action, description, frequency and duration, location, mode of delivery, follow-up), confounding variables, goal of intervention (management of condition or curative), subjective quantitative measures used, physiological measures used, qualitative measures used, data analysis method(s) used, findings, author conclusions and author limitations.

Expert panel

Two meetings were held with the expert panel, who voluntarily contributed knowledge of lived experience of fatigue interventions as participants, carers and health and care professionals. An existing community network and the chronic fatigue service were approached to recruit to the panel along with those with academic interest and six participants attended. They offered initial context to confirm the search strategy and to inform the critical appraisal of findings. The group were actively engaged with and advised on the acceptability of interventions although were not expert in the review methods.

Data analysis

Narrative synthesis

Narrative synthesis as described by Popay et al. [30] was used as the overarching framework of analysis and was used in combination with the statistical analysis to develop a textual summary account of the selected studies. This approach provided a non-linear framework comprising four elements enabling an iterative approach to analytical activities: developing a theory of how an intervention works and why; preliminary synthesis of findings; exploration of relationships; and assessing the robustness of the synthesis. The aim of narrative synthesis is not to reach a single conclusion or ‘overall answer’ to the research question, but rather to develop a trustworthy and compelling story by summarising the evidence, to present theoretical insights that aid and inform understanding of underlying mechanisms of action [30]. Synthesising the evidence in this way increases the chances of findings being used to inform real-world policy and practice.

First, an initial description of results from included studies and then a statistical analysis was conducted using a common rubric across all quantitative studies. This tabulation of results and enabled the examination of similarities and differences between outcomes and population groups according to fatigue severity of participants at baseline, intervention type, intervention duration and intensity and intervention effect size. Selecting interventions by virtue of reported effectiveness then enabled the comparison of components and characteristics. The findings were considered for areas of consensus and divergence, and a theory of outcome effectiveness for fatigue was developed. Finally, the robustness of the synthesis was assessed by critical reflection.

Statistical analysis

A standardised scale was developed to enable comparison of fatigue outcomes, which were assessed using 11 different fatigue measures across the included studies (see S2 File Comparison of fatigue measurement scales). The most used measure was the Chalder fatigue scale (n = 15). Any reported outcomes included dichotomous, or bimodal response scores were excluded from this analysis. Standardising the results was important to allow all available evidence to be included to avoid the risks associated with small overall sample sizes and wide confidence intervals. This method is valid where instruments measure the same or a similar construct [31].

Reported outcomes of fatigue interventions were converted to a common 0–100 scale, with 0 denoting no fatigue and 100 denoting the worst possible fatigue severity. Reported fatigue severity scores were thus expressed as a percentage of the maximum possible score for each given self-report fatigue scale, as reported in previous systematic reviews [3234]. Changes in fatigue severity from baseline to post-intervention were calculated for both the control and experimental groups and the change in fatigue severity between baseline and follow-up was calculated. Mean differences in fatigue between the means of each experimental group and the control following the intervention in each study, as well as the 95% confidence intervals (CIs) for the mean difference.

Significance testing was conducted to assess statistical significance of differences in fatigue severity between groups following the intervention within each study. For studies where there was a control group and a single experimental group, independent sample t-tests were used; for studies where there was a control group and two or more experimental groups, one-way analysis of variance (ANOVA) was used to assess whether the fatigue severity of participants in one or more of the experimental groups was significantly different to the control group. If a significant difference was identified, Tukey’s HSD post-hoc tests were conducted to determine which of the experimental groups differed significantly from the control. For both the t-test and the ANOVA analyses, a p-value of less than 0.05 was considered to be significant.

Standardised mean differences (SMD) were calculated as a secondary summary statistic to express the size effect of each intervention relative to the variability observed in that study. SMDs were calculated by subtracting the mean score of each intervention group from the mean score of the control group, divided by the pooled standard deviation of both groups at the post-intervention assessment [31]. Cohen’s d is the appropriate effect size measure if both groups have similar standard deviations and are of the same size. Hedges’ g, provides a measure of effect size weighted according to the relative size of each sample, and is an alternative where there are different sample sizes between groups. For both Cohen’s d and Hedges’ g, standardised mean difference cut-off points of 0.20, 0.50, and 0.80 can be considered to represent a small, moderate, and large effect, respectively [35]. All statistical analyses were conducted within SPSS (IBM SPSS Statistics 24.0).

Content analysis

Whilst the heterogeneity of intervention descriptions and outcome measures limited the ability to carry out a meta-analysis, the narrative synthesis enabled the further analysis of the characteristics of the interventions. We developed summary tables, to further consider the clinical context, intervention components, and direction of effect in relation to the participant experience of fatigue. Recognising the complexity of effect on psychological and functional wellbeing, it was possible to identify the complex descriptions of protocols and consider issues such as the training and competency associated with delivery and the recipient’s personal context and commitment to sustained involvement, given the nature of their condition. All extracted data was used to identify a number of ‘threads’ [36] associated with the most effective interventions, based on the face validity to participants. This process enabled the synthesis of findings and a method to describe the rationale for managing fatigue and recommendations for the treatment of long Covid.

Results

Study selection

The search process yielded 13,613 results, which was reduced to 6,777 records after removal of duplicates. After review of abstracts, 115 papers were selected for full text screening, of which 40 were selected for inclusion in review. Papers were excluded at full text screening stage for reasons including being uncontrolled, not assessing fatigue as a primary outcome, not being published in English language, having only pharmacological components, having unclear analysis, and not having high validity. 37 out of the final 40 papers were deemed appropriate for further statistical analysis due to measures used (Fig 1).

Fig 1. PRISMA flow diagram.

Fig 1

Adapted from Moher et al. [37].

Study characteristics

Final selection yielded 40 studies reflecting an international body of literature spanning three continents, Europe, America, and Asia, plus one paper from Australia. Around 40% of the studies selected were published since 2016, while the remainder were published between 2003 and 2015. Publications include scientific reports and clinical trials in a range of psychological and physical health journals, including specific focus on Pain Management and Chronic Fatigue Syndrome (CFS). The fatigue interventions reported were associated with several post-viral syndromes, in 25 cases with CFS/ME, in nine cases for fibromyalgia and eight linked to unexplained fatigue. The mean participant age reported in individual studies ranged from 33.2 to 57.6 years, with women making up most of the participants (Table 1).

The selected studies reported a wide variety of approaches and treatments aimed at reducing fatigue. Broadly, these can be categorised as follows—although a few interventions straddle one or more categories. Firstly, those which are purely physiological in nature, such as transcranial magnetic [38]/transcutaneous electrical nerve [39] stimulation, hyperbaric oxygen therapy [40], homeopathy [41], acupuncture [4246] and its variants–e.g. Tuina [47] and moxibustion [48]–all of which aim to stimulate or otherwise influence physiological processes (for example, increasing oxidation of the blood). Second, psychological or psycho-spiritual therapies such as cognitive behavioural therapy (CBT) [14, 4953], behavioural self-regulation [54], operant learning [55] and Three Principles/Innate Health [56] which focus on influencing cognitive processes, building self-awareness and education. Third, physical interventions that require active physical input or participation from the individual, and which may or may not comprise a ‘mind-body’ component, such as Graded Exercise Therapy (GET) [5762], Oriental Medicine Music Therapy [63], Tai Ji Quan [64] and yoga [65], and finally multi-modal interventions which comprise a either a mixture of the afore-mentioned activities or one or more activities plus pharmacological components [6670]. Only one intervention focused solely on social support with no participation or activity undertaken by the fatigued individual [71]. All interventions were controlled and typically compared with ‘usual care’ (a medical or multidisciplinary team general assessment and treatment) or a waiting list for the same.

In nine studies, the interventions were delivered solely in community settings such as general and specialist clinics [41, 43, 46, 47, 55, 58, 65, 70, 72], while a further nine comprised elements of home-based self-management combined with primary or outpatient care [53, 54, 61, 62, 64, 71, 7375]. Two studies combined primary and secondary/specialist care [51, 52], while 11 studies combined secondary/specialist care with outpatient care and laboratory-based assessment [14, 38, 42, 49, 50, 57, 59, 60, 63, 67, 68]. Five studies were entirely laboratory-based [40, 44, 45, 48, 76], while four studies omitted details of treatment setting [39, 56, 66, 69]. In the majority of studies (28 of 40), treatment was administered or delivered by either clinically trained professionals or trained specialists (such as in the case of yoga and acupuncture). Four interventions were entirely or partly self-led by the participant at home, while in a small number of studies the intervention was delivered by the researchers themselves. One intervention was delivered by students with a background in psychology or social work [71]. Duration of interventions was highly variable, ranging from four days to 12 months, although the majority of studies adopted interventions lasting for 12 weeks or less.

Effectiveness of interventions

The intervention that resulted in the largest mean difference in fatigue severity for participants compared to a control was the Three Principles/Innate Health (3P/IH) psycho-spiritual mental health education programme [56] (MD -39.0, 95% CI -51.8 to -26.2, SMD = 1.670) (Fig 2). Interventions employing group-based CBT were also found to result in large reductions in fatigue severity compared to a control (MD -27.5, 95% CI -33.7 to -21.3, SMD = 1.170 [50]; MD -23.7, 95% CI -29.2 to -18.2, SMD = 2.266 [51]).

Fig 2. Mean differences (95% Confidence Intervals (CI), Inverse Variance (IV)) for fatigue in studies assessing the effectiveness of interventions for reducing fatigue severity.

Fig 2

Fatigue is expressed on a 0–100 scale. Studies are ordered by the mean difference between the average score of participants in the intervention group and participants in the control group. The baseline fatigue severity of each group and the effect size (standardised mean difference (SMD, Cohen’s d and Hedges’ g)) of each intervention is also listed. ǂ = non-inferiority trial to see if one treatment is no less effective than the other, ¥ = fatigued individuals vs healthy controls.

A diverse range of interventions were found to result in significant reductions in fatigue severity compared to a control, including oriental medicine music therapy [63] (MD -21.7, 95% CI -30.4 to -12.9, SMD = 1.237); individual CBT [67] (MD -12.9, 95% CI -15.1 to -10.8, SMD = 1.784); yoga [65] (MD -20.0, 95% CI -34.6 to -5.4, SMD = 0.978); acupuncture [42] (MD -18.2, 95% CI -23.5 to -12.8, SMD = 0.984); and social support [71] (MD -12.0, 95% CI -20.7 to -3.4, SMD = 0.826).

Several studies employed interventions that did show benefits but with smaller effect level, such as operant learning [55] (MD -10.6, 95% CI -22.5 to 1.3, SMD = 0.520) and different forms of physical activity, such as GET [49] (MD -11.5, 95% CI -17.6 to -5.4, SMD = 0.524) and self-regulation based physical activity [61] (MD -9.9, 95% CI -16.3 to -3.4, SMD = 0.513).

Several interventions demonstrated either little or no benefit to individuals compared to standard care in terms of reducing fatigue severity, such as transcutaneous electrical nerve stimulation (TENS) [39] (MD -6.0, 95% CI -16.9 to 4.9, SMD = 0.239); Tai Ji Quan [64] (MD -0.4, 95% CI -9.6 to 8.9, SMD = 0.023) and supportive listening [75] (MD 1.06, 95% CI -1.4 to 3.6, SMD = -0.111). In addition, the efficacy of various forms of medication in reducing fatigue were investigated, however, were largely found to have little or no effect, for example: Mirtazapine [69] (MD -3.0, 95% CI -6.8 to 0.7, SMD = 0.447) and Doxycycline [67, 68] (MD 6.3, 95% CI 3.7 to 8.8, SMD = -0.752; MD 8.75, 95% CI 6.36 to 11.14, SMD = -1.120).

Only nine trials performed follow-up assessments of fatigue severity following the initial intervention (e.g. at 6–12 months following intervention) (See S3 File). Of these, only three interventions were found to have resulted in significant sustained reductions in fatigue; acupuncture [42] (MD -15.7, 95% CI -21.5 to -9.8, SMD = 0.773); self-management and web diaries [54] (MD -7.0, 95% CI -11.8 to -2.2, SMD = 0.514); and multidisciplinary rehabilitation [70] (MD -12.9, 95% CI -20.8 to -5.1, SMD = 0.454).

Characteristics of effective interventions

A diverse range of intervention approaches appear to have had a positive effect on severely fatigued individuals. A closer inspection of effective interventions reveals some complexity in terms of potentially uncontrolled elements (Table 2). For example, six out of 17 effective interventions comprised CBT delivered mostly as group interventions although in one case as a long series of traditional one to one session over 24 weeks [67]. Additional components such as peer support, structured or self-managed exercise programmes and body awareness therapy, provided additional value to participants insofar as social participation, peer support and joke-telling were specifically included. These elements may improve intervention acceptability, as has been acknowledged by at least one of the authors [51]. The effective CBT interventions in this review are inaccurately described as ‘psychological therapies’ given the additional social foci.

Table 2. Name of intervention with specific activities and components.

Author (Year) Intervention Intervention Activities/Components
Heald (2019) CBT (Group) Group CBT with joke-telling and peer support over 8 weeks
Keijmel (2017) CBT 24 weeks individual CBT
El Mokadem (2020) Three Principles/Innate Health Psycho-spiritual education comprising weekly educational videos, reading materials, webinars, individual coaching sessions, Facebook group over 8 weeks
Lee (2015) Oriental Medicine Music Therapy Relaxation, singing and music-making activities with traditional Korean instruments, 2–3 times/week over 2 weeks
Wiborg (2015) CBT (Small Group) CBT, patient feedback to group, 14 sessions over 6 months
CBT (Large Group) CBT, patient feedback to group, 14 sessions over 6 months
Kim (2015) Acupuncture + SMC 10 sessions of body acupuncture treatment for 4 weeks, 2 to 3 times/week
Oka (2014) Isometric Yoga + Conventional Pharmacotherapy 20-minute yoga session with instructor, 4 times over 2 months, home practice with DVD and booklet, conventional pharmacotherapy (details not stated)
Stubhaug (2008) Comprehensive CBT 2 x 1.5 hr sessions of group CBT/week, 1.5 hr body awareness therapy/week, self-managed exercise programme with exercise diary over 24 weeks
Weatherley-Jones (2004) Homeopathic Medication Classical homeopathic prescribing on a bespoke basis, monthly over 6 months
Jason (2010) Social support Support ‘buddies’ providing emotional support and functional support (such as household tasks), 2 hrs/week over 4 months
Kim (2015) Sa-am Acupuncture + SMC 10 sessions of Sa-am acupuncture and usual care for 4 weeks, 2–3 times/week
Friedberg (2016) Behavioural self-management with paper diary Pedometer use, answer daily questions via a paper diary to assess increases in activity or exercise, pacing of activities, greater exposure to pleasant activities, coping practices over 3 months
Marques (2017) Self-regulation Based Physical Activity 2 x motivational interviewing sessions, 2 x self-regulation-based telephone counselling sessions, information booklet, self-regulation-based workbook divided into 4 steps each one focusing on specific self-regulation cognitions and skills, pedometer use over 12 weeks
Clark (2017) Guided graded exercise self-help plus specialist medical care Six-step programme of graded exercise self-management based on the approach of GET, up to 3 support sessions by telephone/Skype
Marques (2014) Self-regulation Based Physical Activity 2 x motivational interviewing sessions, information booklet, self-regulation-based workbook divided into 4 steps each one focusing on specific self-regulation cognitions and skills, pedometer use over 12 weeks
O’Dowd (2006) CBT (Group) CBT, structured incremental exercise programme following group discussion, bi-weekly over 16 weeks
Friedberg (2016) Behavioural self-management with web-based diary Pedometer use, answer daily questions to assess increases in activity or exercise, pacing of activities, greater exposure to pleasant activities, coping practices over 3 months
White (2011) CBT + SMC CBT (fear avoidance theory), specialist medical care over 24 weeks
GET + SMC Graded exercise therapy (deconditioning and exercise intolerance theory), specialist medical care over 24 weeks
Ng (2013) Acupuncture Standard acupuncture (Traditional Chinese Medicine), 8 sessions over 4 weeks

Standardised mean difference (SMD); Cognitive behavioural therapy (CBT); Chronic Fatigue Syndrome (CFS); Graded Exercise Therapy (GET); Randomised controlled trial (RCT); Standard Medical Care (SMC).

Three studies adopted self-regulation/behavioural self-management approaches with a focus on pacing, which appeared to be effective for those with relatively greater levels of fatigue severity, especially when supported by additional elements including Motivational Interviewing and counselling [61, 62]. Graded Exercise Therapy was shown to be effective only when adopted as a self-management strategy and supported by regular counselling sessions or specialist care.

Two successful interventions adopted a ‘mind-body’ approach, one focusing on isometric yoga (with participants receiving pharmacological therapy) [65] and the other on psycho-spiritual education to improve body awareness and promote innate health [56]; while quite different in method and requirements of the participant, both appeared effective at symptom reduction in those with relatively higher levels of fatigue. Acupuncture and Oriental Medicine Music Therapy [63] showed positive effects in those with relatively lower levels of fatigue. Classical homeopathy, which arguably needed the least ‘active input’ by the participant, was shown to be effective in only one study. The study with the most severely fatigued individuals [71] adopted a very different approach to others, requiring nothing of the participant and focusing on allowing the fatigued individual to rest whilst providing functional and social support in the guise of a visiting student to support with household tasks. This ‘hands off’ approach was shown to be highly effective at reducing fatigue in a severely fatigued sample group.

There does not appear to be any links between length of treatment time and effectiveness of intervention.

Discussion

This study uses a systematic review process to identify evidence of effectiveness of interventions that reduce fatigue following viral infection. The authors sought to elicit learning that can be applied in practice, and which can be used to support service planning for fatigue management in the context of long Covid [77].

A vast range of treatment components, delivery modes and intervention durations were observed in this review. Despite significant levels of effectiveness reported in multiple studies, the range and complexity of intervention approaches adopted, and the homogeneity of participants, precludes a conclusive answer to the question, ‘what works, and for whom’. Though international in scope, the current research evidence applies to a narrow range of people with fatigue, a relatively homogeneous group of patients in an age group between 45–55, with a mean age of 49 yrs. There is a considerable and growing realisation that a range of social and economic determinants may inform Covid-19 outcomes [78]; for example, lower family income and poor health status together with lack of physical activity, hypertension, and persistent Covid-19 symptoms are associated with recovery from fatigue-type symptoms [21]. A few key principles, however, can be drawn from the findings of this review, especially when considered in the context of the ‘lived experience’ of patients and practitioners, and the practical and operational considerations of wide-scale implementation with large numbers of patients with long Covid. In accordance with NICE guidance 2020, graded exercise is not indicated [79], but it seems that a range of activities and treatments can be offered in the context of individual choice and cultural context.

The importance of person-centred planning

The severity of fatigue experienced by participants is a factor does not correlate with the type of intervention used but the real-world implementation is demonstrated in studies that use home-based interventions with remote or highly practical support for those with the most severe symptoms. The rationale for these treatments is the continuing engagement and optimisation of daily life activities [5]. Symptom management is therefore based upon individualised assessments and tailored to the patient’s situation and the minimisation of exertion; energy conservation, which has been referred to as the “Envelope Theory” [71]. Where an intervention has focused entirely on social and functional support and has legitimised inactivity completely [71], it appears to have been effective in reducing symptoms for the most severely fatigued individuals. Where Wearden et al. [75] introduces exercise, the programme is devised collaboratively with the patient rather than prescribed based on exercise testing, as in graded exercise therapy. Generally, the patient-centred goals of treatment are not explicit in the literature, and yet those interventions that focus on individual experience and the functional impacts of fatigue on everyday life demonstrate some of the best outcomes.

The importance of describing the participation required

Multi-modal approaches to interventions are under- reported overall or described as educational or technical interventions in UK, European and USA based studies. This is although many have social or emotional support elements to delivery that may contribute to effectiveness. This may reflect the demand from patients to address their physiological condition and rather than focus on psychological components arising from fatigue. Yoga and acupuncture have no such dilemma and participants engage in treatment appreciating the holistic nature of the treatment activity that is meant to strengthen mind and body but are described in their cultural context where homeopathic interventions are the norm. Given the range of symptoms associated with long Covid and the known aetiology of the condition, it is perhaps important to recognise that patients expect allopathic interventions and may be very unused to needing psychological support. The early indications from the recent literature about rehabilitation services for long Covid indicate that the management of fatigue is a central focus and that an educational approach is being adopted incorporating energy management and rest [80], similar to those advocated by Friedberg [54] and Marques [61, 62].

The importance of strengthening mind and body

According to traditional Oriental medicine, chronic fatigue is the result of an unbalanced state among inter-functioning organs, or a deficiency in vital energy, known as qi, and that by inserting acupuncture needles into specific points in the body this energy flow is brought back into proper balance. Yoga, while presented by a study in this review as a physical activity requiring active participation of the fatigued individual, is nonetheless recognised as a mind-body discipline that over time can contribute to changes in life perspective, increased self-awareness, and raised expectations regarding personal energy and life enjoyment [81]. Fatigue is both depressing and de-conditioning [82] and methods that enable people to engage with early rehabilitation are advocated [83] and it is becoming apparent that a broad range of accessible services are needed to offer rehabilitation as a means to prevent individuals from chronic illness [84].

The importance of skilled and competent practitioners

Most interventions identified are based on high level competencies although there are those that do not require delivery by cognitive behavioural therapists or allied health professionals [71, 75]. The scale of the long Covid epidemic and numbers of people expected to need support, suggest that the effective interventions offering remote monitoring and support may be highly acceptable and enable access to those from more marginal communities who are not yet accessing long Covid services. Interventions offered in the context of community rehabilitation need to be based on their scalability and real-world practicality, as well as efficacy. Whilst early consensus advocates for holistic care, investigation of specific symptom clusters and individualised rehabilitation [85] there is a need to recognise the potential to consider awareness raising and fatigue management across community services and the wider social care workforce.

The importance of observational research

The fatigue interventional studies included here, reflect a highly diverse range of methods which are assessed for effectiveness and some which can be replicated in further studies with people who have long Covid. There are some group interventions that appear to work well and others offering minimal, remote interventions that could be scaled to meet the probable demand. The remaining interventions may not be culturally acceptable or are not available to be prescribed via health and social care provision. There are methods requiring careful observational studies with clinical academic designs, scaled to provide guidance for learning in a practice context. Systematic process evaluation is required to ensure that the academic fraternity uses public and patient involvement to understand the acceptability of complex evaluations that are based on fatigue experience in the long Covid population. Rapid evaluation of the acceptable activities and health outcomes are urgently needed.

Strengths and limitations

The review is carried out to a high quality and includes systematic mixed methods of synthesising the findings and critically evaluating their useful in the context of long Covid fatigue management. In the final selection only papers adopting a quantitative methodology were included and very limited qualitative or mixed methods data was available. It focuses on the critical appraisal of the research evidence in relation to the mechanism of the interventions and on the measurement of effectiveness. These two elements of analysis were deemed to be of priority interest when seeking to build a rationale for planning further fatigue interventions and looking for a robust theory to underpin interventions for fatigue in long Covid. It is a strength of this paper that we have undertaken an inclusive analysis across a range of treatment modalities, allowing in the future for a range of novel treatments to be considered and analysed. In the additional appraisal of on-going clinical studies there were no further interventional studies that needed to be included in this review but a wide variety of studies into idiopathic chronic fatigue and also some that focussed on the needs of children and young people, outside the scope of this investigation.

The authors acknowledge the limitations of the narrative synthesis process used to assess and summarise the findings within this review. Quality of evidence is varied, and in developing a narrative to describe and explain the varied results, assumptions have been made to fill gaps and manage uncertainties. For example, the lack of focus in most studies on the functional abilities and baseline severity of fatigued individuals means that effectiveness cannot fully be considered on a ‘like-for-like’ basis, and this may call into question the overall validity and generalisability of the findings. In tabulating the characteristics of effective interventions alongside baseline fatigue severity in this review, an attempt has been made to limit assumptions about the condition of participating individuals; nonetheless, the lack of information regarding the functional capabilities of the study participants before they participated in the intervention was a key topic of discussion during the synthesis process.

The findings suggest a critical need for further research that includes a diversity of ages and socio-economic groups, and improved reporting of demographic and cultural variation in the management of fatigue. long Covid may affect 10% of the UK population but a far higher number of people who had Covid were from the worst deprived communities [86] suggesting that long Covid will similarly be distributed and may lead to significant inequalities of service provision. There are no studies that target the assessment and experience of fatigue and the management of fatigue with socially and economically deprived people.

Conclusion

The aim of the study was to systematically review the literature associated with fatigue management interventions, their characteristics, and outcomes, and to identify treatments that may be useful in the management of long Covid. NICE guidelines were published [87], but the evidence relating to fatigue management treatments for long Covid were limited. The findings of this study suggest that the fatigue management research is highly focussed on a narrow participant demographic, of which 18 interventions demonstrated no effect in managing fatigue symptoms. The selected literature, demonstrates how self-rated fatigue scales are used to report the effect of complex interventions, which is a limitation of the body of research as a whole. Synthesis suggests that long Covid fatigue management may be beneficial when: a) physical and psychological support, is delivered in groups where people can plan their functional response to fatigue [27]; and b) where strengthening rather than endurance is used to prevent deconditioning; and c) where fatigue is regarded in the context of an individual’s lifestyle and home-based activities are used. Further research is required into fatigue management with more diverse populations.

Supporting information

S1 Checklist. PRISMA 2020 checklist.

(DOCX)

S1 File. Search strategy.

Table 1. MEDLINE Search; Table 2. ProQuest Search.

(DOCX)

S2 File. Comparison of fatigue measurement scales.

(DOCX)

S3 File. Overview of intervention effectiveness using standardised measures, including follow-up assessments.

(DOCX)

Acknowledgments

The authors thank all the members of an expert advisory group who met twice during the study and who shared their experience of fatigue, service access and treatment and commented on the previous research into fatigue, also commenting on scope, initial findings and early research outcomes.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

SFD received part funding from Westfield Health https://www.westfieldhealth.com/my-westfield/overview for the purpose of a research assistant (namely AW and MT) only, all other contributions were undertaken under the auspices of the employment contract of the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Jason L, Evans M, Brown M, Porter N. What is fatigue? Pathological and nonpathological fatigue. PM R. 2010;2(5):327–31. doi: 10.1016/j.pmrj.2010.03.028 [DOI] [PubMed] [Google Scholar]
  • 2.Christodoulou C. The Assessment and Measurement of Fatigue. MIT Press. 2005:19–35. [Google Scholar]
  • 3.Jason L, Choi M. Dimensions and Assessment of Fatigue. In: Watanabe Y, Evengord B, Natelson B, Jason L, Kuratsune H(), editors. Fatigue Science for Human Health. Tokyo: Springer; 2008. p. 1–16. [Google Scholar]
  • 4.Mock V. Fatigue management: evidence and guidelines for practice. Cancer. 2001;92(6):1699–707. doi: [DOI] [PubMed] [Google Scholar]
  • 5.Kos D, Duportail M, D’hooghe M, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. 2007;13(8):996–1003. doi: 10.1177/1352458507078392 [DOI] [PubMed] [Google Scholar]
  • 6.Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database of Systematic Reviews. 2012;11. doi: 10.1002/14651858.CD006145.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cramp F, Hewlett S, Almeida C, Kirwan J, Choy E, Chalder T, et al. Non-pharmacological interventions for fatigue in rheumatoid arthritis. Cochrane Database of Systematic Reviews. 2013;8. doi: 10.1002/14651858.CD008322.pub2 [DOI] [PubMed] [Google Scholar]
  • 8.Sadeghniiat-Haghighi K, Yazdi Z. Fatigue management in the workplace. Industrial Psychiatry Journal. 2015;24(1):12–7. doi: 10.4103/0972-6748.160915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mucke M, Mochamat m, Cuhls H, Peuckmann-Post V, Minton O, Stone P, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database of Systematic Reviews. 2015;5. doi: 10.1002/14651858.CD006788.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Elbers R, Verhoef J, van Wegen E, Berendse H, Kwakkel G. Interventions for fatigue in Parkinson’s disease. Cochrane Database of Systematic Reviews. 2015;10. doi: 10.1002/14651858.CD010925.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.NICE. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management. Clinical guideline [CG53]. In press 2007. [Google Scholar]
  • 12.Larun L, Brurberg K, Odgaard-Jensen J, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database of Systematic Reviews. 2019;10. doi: 10.1002/14651858.CD003200.pub8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Marques M, De Gucht V, Gouveia M, Leal I, Maes S. Differential effects of behavioral interventions with a graded physical activity component in patients suffering from Chronic Fatigue (Syndrome): An updated systematic review and meta-analysis. 40. Clin Psychol Rev. 2015;40:123–37. doi: 10.1016/j.cpr.2015.05.009 [DOI] [PubMed] [Google Scholar]
  • 14.White P, Goldsmith K, Johnson A, Potts L, Walwyn R, DeCesare J, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. The Lancet. 2011;377(9768):823–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management [GID-NG10091]. National Institute for Health and Care Excellence (NICE). [Internet].; 2021 [cited June 2021]. Available from: https://www.nice.org.uk/guidance/indevelopment/gid-ng10091.
  • 16.Turner-Stokes L, Wade D. Updated NICE guidance on chronic fatigue syndrome. BMJ. 2020;371. doi: 10.1136/bmj.m4774 [DOI] [PubMed] [Google Scholar]
  • 17.Islam M, Cotler J, Jason L. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior. 2020;8(2):61–9. [Google Scholar]
  • 18.Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypothesis. 2020;144. doi: 10.1016/j.mehy.2020.110055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–5. doi: 10.1001/jama.2020.12603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Goertz Y, Van Herck M, Delbressine J, Vaes A, Meys R, Machado F, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Elsevier Public Health Emergency Collection. 2020;7(2). [Google Scholar]
  • 21.Islam M, Ferdous M, Islam U, Mosaddek A, Potenza M, Pardhan S. Treatment, Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021;18(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. Elsevier Public Health Emergency Collection. 2020;81(6). doi: 10.1016/j.jinf.2020.08.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370. doi: 10.1136/bmj.m3026 [DOI] [PubMed] [Google Scholar]
  • 24.Kim G, Wang M, Pan H, Davidson G, Roxby A, Neukirch J, et al. A Health System Response to COVID-19 in Long-Term Care and Post-Acute Care: A Three-Phase Approach. J Am Geriatr Soc. 2020;68(6):1155–61. doi: 10.1111/jgs.16513 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. 2020;32(8):1613–20. doi: 10.1007/s40520-020-01616-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.NHS. NHS launches 40 ‘long COVID’ clinics to tackle persistent symptoms. In press; 2020. [Google Scholar]
  • 27.Perego E, Callard F, Stras L, Melville-Johannesson B, Pope R, Alwan N. Why the Patient-Made Term ’Long Covid’ is needed. Wellcome Open Research. 2020;5:224. [Google Scholar]
  • 28.Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372(405). doi: 10.1136/bmj.n405 [DOI] [PubMed] [Google Scholar]
  • 29.Savitz D, Wellenius G, Trikalinos T. The Problem With Mechanistic Risk of Bias Assessments in Evidence Synthesis of Observational Studies and a Practical Alternative: Assessing the Impact of Specific Sources of Potential Bias. Am J Epidemiol. 2019;188(9):1581–5. doi: 10.1093/aje/kwz131 [DOI] [PubMed] [Google Scholar]
  • 30.Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. Lancaster University; 2006. [Google Scholar]
  • 31.Murad M, Wang Z, Chu H, Lin L. When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation. BMJ. 2019;364(4817). doi: 10.1136/bmj.k4817 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shaheed C, Maher C, Buchbinder R, Ng B, Enke O, Guzowski R, et al. Efficacy and harms of orally, intramuscularly or intravenously administered glucocorticoids for sciatica: A systematic review and meta-analysis. European Journal of Pain. 2019;24:518–35. [DOI] [PubMed] [Google Scholar]
  • 33.Pinto R, Maher C, Ferreira M, Ferreira P, Hancock M, Oliveira V, et al. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ. 2012;344(497). doi: 10.1136/bmj.e497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Machado G, Maher C, Ferreira P, Pinheiro M, Lin C, Day R, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350(1225). doi: 10.1136/bmj.h1225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd Edition ed.). Routledge; 1988. [Google Scholar]
  • 36.O’Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341(4587). doi: 10.1136/bmj.c4587 [DOI] [PubMed] [Google Scholar]
  • 37.Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(2535). [PMC free article] [PubMed] [Google Scholar]
  • 38.Fitzgibbon B, Hoy K, Knox L, Guymer E, Littlejohn G, Elliot D, et al. Evidence for the improvement of fatigue in fibromyalgia: a 4-week left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation randomized-controlled trial. European journal of pain. 2018;22(7):1255–67. doi: 10.1002/ejp.1213 [DOI] [PubMed] [Google Scholar]
  • 39.Dailey D, Rakel B, Vance C, Liebano R, Amrit A, Bush H, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain. 2013;154(11):2554–62. doi: 10.1016/j.pain.2013.07.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Van Hoof E, Coomans D, De Becker P, Meeusen R, Cluydts R, De Meirleir K. Hyperbaric Therapy in Chronic Fatigue Syndrome. J Chronic Fatigue Syndrome. 2003;11(3):37–49. [Google Scholar]
  • 41.Weatherley-Jones E, Nicholl J, Thomas K, Parry G, McKendrick M, Green S, et al. A randomized, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res. 2004;56(2):189–97. doi: 10.1016/S0022-3999(03)00377-5 [DOI] [PubMed] [Google Scholar]
  • 42.Kim J, Seo B, Choi J, Kim H, Kim T, Lee M, et al. Acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue: a multicenter, nonblinded, randomized controlled trial. BMC Trials. 2015;16(314). doi: 10.1186/s13063-015-0857-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mist S, Jones K. Randomized Controlled Trial of Acupuncture for Women with Fibromyalgia: group Acupuncture with Traditional Chinese Medicine Diagnosis-Based Point Selection. Pain Medicine. 2018;19(9):1862–71. doi: 10.1093/pm/pnx322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ng S, Yiu Y. Acupuncture for chronic fatigue syndrome: a randomized, sham-controlled trial with single-blinded design. Alternative Ther. 2013;19(4):21–6. [PubMed] [Google Scholar]
  • 45.Shu Q, Wang H, Litscher D, Wu S, Chen L, Gaischek I, et al. Acupuncture and Moxibustion have Different Effects on Fatigue by Regulating the Autonomic Nervous System: a Pilot Controlled Clinical Trial. Scientific Reports. 2016;6. doi: 10.1038/srep37846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.UÄŸurlu F, Sezer N, Aktekin L, Fidan F, Tok F, Akkuş S. The effects of acupuncture versus sham acupuncture in the treatment of fibromyalgia: a randomized controlled clinical trial. Acta Reumatol Portuguesa. 2017;42(1):32–7. [PubMed] [Google Scholar]
  • 47.Wu S, Liu L. Observation on therapeutic efficacy of tuina plus cupping for chronic fatigue syndrome. Journal of Acupuncture and Tuina Science. 2020;18(1):53–8. [Google Scholar]
  • 48.Kim H, Yoo S, Park H, Son C. Indirect moxibustion (CV4 and CV8) ameliorates chronic fatigue: a randomized, double-blind, controlled study. Journal of alternative and complementary medicine. 2013;19(2):134–40. doi: 10.1089/acm.2011.0503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.O’Dowd H, Gladwell P, Rogers C, Hollinghurst S, Gregory A. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. Health Technology Assessment—NIHR Journals. 2006;10(37). doi: 10.3310/hta10370 [DOI] [PubMed] [Google Scholar]
  • 50.Wiborg J, van Bussel J, van Dijk A, Bleijenberg G, Knoop H. Randomised controlled trial of cognitive behaviour therapy delivered in groups of patients with chronic fatigue syndrome. Psychother Psychosom. 2015;84(6):368–76. doi: 10.1159/000438867 [DOI] [PubMed] [Google Scholar]
  • 51.Heald A, Barber L, Jones H, Farman S, Walther A. Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions. Medicine. 2019;98:39. doi: 10.1097/MD.0000000000016720 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Sharpe M, Goldsmith K, Johnson A, Chalder T, Walker J, White P. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. The Lancet, Psychiatry. 2015;2:1067–74. doi: 10.1016/S2215-0366(15)00317-X [DOI] [PubMed] [Google Scholar]
  • 53.Tummers M, Knoop H, Bleijenberg G. Effectiveness of stepped care for chronic fatigue syndrome: a randomized noninferiority trial. J Consult Clin Psychol. 2010;78(5):724–31. doi: 10.1037/a0020052 [DOI] [PubMed] [Google Scholar]
  • 54.Friedberg F, Adamowicz J, Caikauskaite I, Seva V, Napoli A. Efficacy of two delivery modes of behavioral self-management in severe chronic fatigue syndrome. Fatigue: Biomedicine, Health & Behavior. 2016;4(3):158–74. [Google Scholar]
  • 55.Racine M, Jensen M, Harth M, Morley-Forster P, Nielson W. Operant Learning Versus Energy Conservation Activity Pacing Treatments in a Sample of Patients With Fibromyalgia Syndrome: a Pilot Randomized Controlled Trial. Journal of pain. 2019;20(4):420–39. [DOI] [PubMed] [Google Scholar]
  • 56.El-Mokadem J, DiMarco K, Kelley T, Duffield L. Three principles/innate health: The efficacy of psycho-spiritual mental health education for people with chronic fatigue syndrome. Spirituality in Clinical Practice. 2020. [Google Scholar]
  • 57.Clark L, Pesola F, Thomas J, Vergara-Williamson M, Beynon M, White P. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. The Lancet. 2017;390:363–73. doi: 10.1016/S0140-6736(16)32589-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ericsson A, Palstam A, Larsson A, Lofgren M, Bileviciute-Ljungar I, Bjersing J, et al. Resistance exercise improves physical fatigue in women with fibromyalgia: a randomized controlled trial. Arthritis research & therapy. 2016;18(176). doi: 10.1186/s13075-016-1073-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Windthorst P, Mazurak N, Kuske M, Hipp A, Giel KE, Enck P, et al. Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: an exploratory pilot study. J Psychosom Res. 2017:6–13. doi: 10.1016/j.jpsychores.2016.11.014 [DOI] [PubMed] [Google Scholar]
  • 60.Fernie B, Murphy G, Wells A, Nikcevic A, Spada M. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome. Behavioural and cognitive psychotherapy. 2016;44:397–409. doi: 10.1017/S135246581500017X [DOI] [PubMed] [Google Scholar]
  • 61.Marques M, Gucht V, Leal I, Maes S. Effects of a Self-regulation Based Physical Activity Program (The ’4-STEPS’) for Unexplained Chronic Fatigue: a Randomized Controlled Trial. Int J Behav Med. 2015;22:187–96. doi: 10.1007/s12529-014-9432-4 [DOI] [PubMed] [Google Scholar]
  • 62.Marques M, de Gucht V, Leal I, Maes S. Efficacy of a randomized controlled self-regulation based physical activity intervention for chronic fatigue: mediation effects of physical activity progress and self-regulation skills. J Psychosom Res. 2017;94:24–31. doi: 10.1016/j.jpsychores.2016.12.012 [DOI] [PubMed] [Google Scholar]
  • 63.Lee J-, Kim S-, Ko S-, Lee S-, Lee J-, Kim M-, et al. The effect of oriental medicine music therapy on idiopathic chronic fatigue. The Journal of Alternative and Complementary Medicine. 2015:1–8. doi: 10.1089/acm.2014.0271 [DOI] [PubMed] [Google Scholar]
  • 64.Maddali Bongi S, Paoletti G, Cala M, Del Rosso A, El Aoufy K, Mikhaylova S. Efficacy of rehabilitation with Tai Ji Quan in an Italian cohort of patients with Fibromyalgia Syndrome. Complementary Therapies in Clinical Practice. 2016;24:109–15. doi: 10.1016/j.ctcp.2016.05.010 [DOI] [PubMed] [Google Scholar]
  • 65.Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K. Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial. BioPsychoSocial medicine. 2014;8(27). doi: 10.1186/s13030-014-0027-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Hansen A, Kvale G, Stubhaug B, Thayer J. Heart rate variability and fatigue in patients with chronic fatigue syndrome after a comprehensive cognitive behavior group therapy program. Journal of Psychophysiology. 2013;27(2):67–75. [Google Scholar]
  • 67.Keijmel S, Delsing C, Bleijenberg G, van der Meer J, Donders R, Leclercq M, et al. Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): a Randomized Controlled Trial. Clinical infectious diseases. 2017;64(8):998–1005. doi: 10.1093/cid/cix013 [DOI] [PubMed] [Google Scholar]
  • 68.Raijmakers R, Keijmel S, Breukers E, Bleijenberg G, van der Meer J, Bleeker-Rovers C, et al. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study. J Psychosom Res. 2019;116:62–7. doi: 10.1016/j.jpsychores.2018.11.007 [DOI] [PubMed] [Google Scholar]
  • 69.Stubhaug B, Lie S, Ursin H, Eriksen H. Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial. British journal of psychiatry. 2008;192:217–23. doi: 10.1192/bjp.bp.106.031815 [DOI] [PubMed] [Google Scholar]
  • 70.Vos-Vromans D, Smeets R, Huijnen I, Koke A, Hitters W, Rijnders L, et al. Multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial. J Intern Med. 2016;279:268–82. doi: 10.1111/joim.12402 [DOI] [PubMed] [Google Scholar]
  • 71.Jason L, Roesner N, Porter N, Parenti B, Mortensen J, Till L. Provision of social support to individuals with chronic fatigue syndrome. NIH Public Access. 2010;66(3):249–58. doi: 10.1002/jclp.20648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Demirbag B, Erci B. The effects of sleep and touch therapy on symptoms of fibromyalgia and depression. Iranian Journal of Public Health. 2012;41(11):44–53. [PMC free article] [PubMed] [Google Scholar]
  • 73.Powell P, Bentall R, Nye F, Edwards R. Patient education to encourage graded exercise in chronic fatigue syndrome: 2-year follow-up of randomised controlled trial. BMJ. 2004;322. doi: 10.1192/bjp.184.2.142 [DOI] [PubMed] [Google Scholar]
  • 74.Ridsdale L, Hurley M, King M, McCrone P, Donaldson N. The effect of counselling, graded exercise and usual care for people with chronic fatigue in primary care: a randomized trial. Psychol Med. 2012;42:2217–24. doi: 10.1017/S0033291712000256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Wearden A, Dowrick C, Chew-Graham C, Bentall R, Morriss R, Peters S, et al. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ. 2010;340. doi: 10.1136/bmj.c1777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Perrin R, Richards J, Pentreath V, Percy D. Muscle fatigue in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and its response to a manual therapeutic approach: A pilot study. International Journal of Osteopathic Medicine. 2011;14:96–105. [Google Scholar]
  • 77.NHS. After-care needs of inpatients recovering from COVID-19. In press; 2020. [Google Scholar]
  • 78.Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. BMJ. 2020;74(11):964–8. doi: 10.1136/jech-2020-214401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Decary S, Gaboury I, Poirier S, Garcia C, Simpson S, Bull M, et al. Humility and Acceptance: Working Within Our Limits With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Journal of Orthopaedic & Sports Physical Therapy. 2021;51(5):197–200. [DOI] [PubMed] [Google Scholar]
  • 80.Parkin A, Davison J, Tarrant R, Ross D, Halpin S, Simms A, et al. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. Journal of Primary Care & Community Health. 2021;12:1–9. doi: 10.1177/21501327211010994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Woodyard C. Exploring the therapeutic effects of yoga and its ability to increase quality of life. Int J Yoga. 2011;4(2):49–54. doi: 10.4103/0973-6131.85485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Surawy C, Hackmann A, Hawton K, Sharpe M. Chronic fatigue syndrome: a cognitive approach. Behav Res Ther. 1995;33(5):535–44. doi: 10.1016/0005-7967(94)00077-w [DOI] [PubMed] [Google Scholar]
  • 83.Faghy M, Arena R, Stoner L, Haraf R, Josephson R, Hills A, et al. The need for exercise sciences and an integrated response to COVID-19: A position statement from the international HL-PIVOT network. Prog Cardiovasc Dis. 2021;19. doi: 10.1016/j.pcad.2021.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Holmes E, O’Connor R, Perry H, Tracey I, Wessely S, Arsenealt L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry. 2020;7(6):547–60. doi: 10.1016/S2215-0366(20)30168-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Nurek M, Rayner C, Freyer A, Taylor S, Jarte L, MacDermott N, et al. Recommendations for the Recognition, Diagnosis, and Management of Patients with Post COVID-19 Condition (’Long COVID’): A Delphi Study. The Lancet. 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health. 2020. Nov 1;74(11):964–8. doi: 10.1136/jech-2020-214401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.COVID-19 guideline scope: management of the long-term effects of COVID-19. [Internet].; 2020 [cited June 2021]. Available from: https://www.nice.org.uk/guidance/ng188/documents/final-scope.

Decision Letter 0

Sinan Kardeş

11 Aug 2021

PONE-D-21-18781

A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?

PLOS ONE

Dear Dr. Fowler Davis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sinan Kardeş, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The aim of this study is to synthesise the literature associated with fatigue interventions to investigate the outcomes that may be applicable to ‘Long Covid’. The article reports an innovative and interesting work.

In the introduction I suggest to add reference to the extent of the long covid syndrome, the correct definition (with further subdivisions depending on whether the symptoms develop before or after four weeks, according to NICE guidelines) and hints of the physiopathology justifying the different treatments.

The aims of the study are well explained. The structure of the study is well organized. The materials and methods sections are discussed in details. I suggest to add in the text the initials of the author who screened the articles. Statistical analysis is well conducted and appropriate.

The results are clearly explained in the text and there are not repetitions between the text and the table. However, I recommend making the table clearer and faster to compare. At the end of each table I would insert the abbreviations used.

In addition, the methods explain that the selected studies were related to post-viral fatigue, in the tables, however, studies related to fibromyalgia symptoms are shown. Please clarify this important concern.

In the discussion section I suggest to add reference to Maccarone MC, Magro G, Tognolo L, Masiero S. Post COVID-19 persistent fatigue: a proposal for rehabilitative interventions in the spa setting [published online ahead of print, 2021 Jun 4]. Int J Biometeorol. 2021;1-3. doi:10.1007/s00484-021-02158-1.

The work weakness has already been identified by the authors in the limitations section. In addition, making an inclusive analysis of methods of medicine recognized by the scientific community, alternative medicine methods, psychological and mind-body interventions can be a limitation because it risks confusing the reader or suggesting solutions not considered to be used at first. It would be appropriate to discuss this point further to avoid confusion.

Reviewer #2: Dear Authors,

It has been a pleasure to review your article and the topic is of great importance in the field of rehabilitation medicine. However, in my opinion, there are some issues that should be addressed.

1. I think, that in the aim of the study should be used “systematically” instead of “systemic”

2. Under Eligibility criteria it is said that “mixed interventions and studies involving a pharmacological component were included only when fatigue outcome measurement data could be extracted. It is not clear whether pharmacological interventions, if they were not mixed with other methods, were included or not. Were studies reporting other interventions, but not reporting fatigue outcome measurement were included? This is confusing. Could you please clarify?

3. Could you, please, clarify the 10% of articles that was screened by the second reviewer? The reasoning behind this approach is not obvious in the text.

4. Results of the quality appraisal of included studies could be reported in Table 1.

5. Could you more precisely describe the expert panel and their role in the study? How many were they? Which professions? Why they can be called experts? How their input affected decisions and results?

6. Since the effect sizes has been calculated based on the outcome measures used in the included studies, it would be important to include these measures in the descriptions of studies (Table 1 or Figure2).

7. Since the information overlaps between Table 2 and Figure 2, consider omitting Table 2 from the article.

8. Although, discussion includes several interesting and important aspects of fatigue treatment, it lacks the summary and interpretation of the direct results of the study.

9. Conclusions should contain only information that directly answers to research question(s) included in the aim of the study and are based on the results of this study. Please, revise conclusions.

Reviewer #3: The authors performed a study addressing “A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?”. There is one point that needs to be corrected.

I think the Conclusion is too long. Can you make it concise? It is unclear what you want to show in this research paper.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Guna Berzina

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 9;16(11):e0259533. doi: 10.1371/journal.pone.0259533.r002

Author response to Decision Letter 0


16 Sep 2021

Response to Reviewers

Additional journal requirements.

The literature search strategy is in Supplementary Information S1_File. The supporting information includes three additional files, which are submitted along with the manuscript. The work does not include any primary data.

Reviewer #1:

The aim of this study is to synthesise the literature associated with fatigue interventions to investigate the outcomes that may be applicable to ‘Long Covid’. The article reports an innovative and interesting work.

Thank you for these comments we appreciate your consideration of our work.

In the introduction I suggest to add reference to the extent of the long covid syndrome, the correct definition (with further subdivisions depending on whether the symptoms develop before or after four weeks, according to NICE guidelines) and hints of the physiopathology justifying the different treatments.

The references 17-21 include the current literature associated with Long Covid syndrome especially in ref 20, the specific range of international thinking associated with the treatment choices. We think the addition of the NICE guideline is out of place given the focus on fatigue management.

The aims of the study are well explained. The structure of the study is well organized. The materials and methods sections are discussed in details. I suggest to add in the text the initials of the author who screened the articles.

We have amended this according to your suggestion.

Statistical analysis is well conducted and appropriate.

Thank you

The results are clearly explained in the text and there are not repetitions between the text and the table. However, I recommend making the table clearer and faster to compare. At the end of each table I would insert the abbreviations used.

We have amended this according to your suggestion.

In addition, the methods explain that the selected studies were related to post-viral fatigue, in the tables, however, studies related to fibromyalgia symptoms are shown. Please clarify this important concern.

We have taken Fibromyalgia to be a post-viral syndrome see www.healthguideinfo.com/fibromyalgia/p113865/ that highlights the Epstein-Barr virus that causes a range of immunodeficiency. The identification of fibromyalgia is widely accepted to our knowledge and understanding.

In the discussion section I suggest to add reference to Maccarone MC, Magro G, Tognolo L, Masiero S. Post COVID-19 persistent fatigue: a proposal for rehabilitative interventions in the spa setting [published online ahead of print, 2021 Jun 4]. Int J Biometeorol. 2021;1-3. doi:10.1007/s00484-021-02158-1.

This reference provides a compelling and interesting treatment option for post viral fatigue but does not appear to be a good fit in the conclusion, but we will be citing in another article related to treatment modalities in sport and leisure facilities.

The work weakness has already been identified by the authors in the limitations section. In addition, making an inclusive analysis of methods of medicine recognized by the scientific community, alternative medicine methods, psychological and mind-body interventions can be a limitation because it risks confusing the reader or suggesting solutions not considered to be used at first. It would be appropriate to discuss this point further to avoid confusion.

Thanks, we have added one sentence to reflect this concern in the analysis but we see this as a strength of the paper P26

Reviewer #2:

Dear Authors, it has been a pleasure to review your article and the topic is of great importance in the field of rehabilitation medicine. However, in my opinion, there are some issues that should be addressed.

Thanks for your review, we have made changes as follows

1. I think, that in the aim of the study should be used “systematically” instead of “systemic”

Thank you, this is corrected on page 5.

2. Under Eligibility criteria it is said that “mixed interventions and studies involving a pharmacological component were included only when fatigue outcome measurement data could be extracted. It is not clear whether pharmacological interventions, if they were not mixed with other methods, were included or not. Were studies reporting other interventions, but not reporting fatigue outcome measurement were included? This is confusing. Could you please clarify?

We have added a statement to clarify on page 5 to say that pharma studies were excluded.

3. Could you, please, clarify the 10% of articles that was screened by the second reviewer? The reasoning behind this approach is not obvious in the text.

We have added the following 10% of the papers screened by a second review author to check for conformity of selection and to quality assess the level of agreement between reviewers

4. Results of the quality appraisal of included studies could be reported in Table 1.

We have now included MMAT quality appraisal scores in Table 1 and have also provided comments about the preliminary use of the MMAT on page 7.

5. Could you more precisely describe the expert panel and their role in the study? How many were they? Which professions? Why they can be called experts? How their input affected decisions and results?

A short additional paragraph has been added page 8.

6. Since the effect sizes has been calculated based on the outcome measures used in the included studies, it would be important to include these measures in the descriptions of studies (Table 1 or Figure2).

Effect size values have been added to Figure 2.

7. Since the information overlaps between Table 2 and Figure 2, consider omitting Table 2 from the article.

Baseline severity and effect size values have been removed from Table 3 (which has also been correctly relabelled as table 2).

8. Although, discussion includes several interesting and important aspects of fatigue treatment, it lacks the summary and interpretation of the direct results of the study.

The summary is in the results section and an additional sentence is in the discussion

9. Conclusions should contain only information that directly answers to research question(s) included in the aim of the study and are based on the results of this study. Please, revise conclusions.

Conclusion is revised in line with your comments.

Reviewer #3:

The authors performed a study addressing “A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?”. There is one point that needs to be corrected.

I think the Conclusion is too long. Can you make it concise? It is unclear what you want to show in this research paper.

This has been revised in line with point 9 of Reviewer 2.

Attachment

Submitted filename: Response to Reviewer Comments.docx

Decision Letter 1

Sinan Kardeş

4 Oct 2021

PONE-D-21-18781R1A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?PLOS ONE

Dear Dr. Fowler Davis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sinan Kardeş, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Dear Authors,

There are some more issues that I think you should clarify:

1. You have included quality appraisal using the MMAT. The scores and interpretation should be mentioned. And since it is score, I don’t think that * is needed in the table 1.

2. Please revise the title of Table 2.

3. You report fatigue severity scores in a common metric scale. I still think that it would be good to address the fact that the fatigue was measured using different scores – how many different scales were there, which were the most commonly used?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Guna Berzina

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 9;16(11):e0259533. doi: 10.1371/journal.pone.0259533.r004

Author response to Decision Letter 1


12 Oct 2021

Thanks for the final clarification you requested;

1. You have included quality appraisal using the MMAT. The scores and interpretation should be mentioned. And since it is score, I don’t think that * is needed in the table 1.

All asterisks have been removed

2. Please revise the title of Table 2.

Thanks, we have amended the title of the table

3 You report fatigue severity scores in a common metric scale. I still think that it would be to address the fact that the fatigue was measured using different scores – how many different scales were there, which were the most commonly used?

We have included a supplementary file 2 that addresses the range of measures and this is referred to on line 219 of page 9 but we have added a small amount of detail to identify the most commonly used in the following section

Finally

We noted that the abstract and the conclusion were not quite the same and so we have slightly amended the abstract to ensure the same message

Attachment

Submitted filename: Response to Reviewer 2 12.10.21.docx

Decision Letter 2

Sinan Kardeş

21 Oct 2021

A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?

PONE-D-21-18781R2

Dear Dr. Fowler Davis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sinan Kardeş, M.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Guna Berzina

Acceptance letter

Sinan Kardeş

29 Oct 2021

PONE-D-21-18781R2

A mixed-methods systematic review of post-viral fatigue interventions: are there lessons for long Covid?

Dear Dr. Fowler Davis:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sinan Kardeş

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA 2020 checklist.

    (DOCX)

    S1 File. Search strategy.

    Table 1. MEDLINE Search; Table 2. ProQuest Search.

    (DOCX)

    S2 File. Comparison of fatigue measurement scales.

    (DOCX)

    S3 File. Overview of intervention effectiveness using standardised measures, including follow-up assessments.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewer Comments.docx

    Attachment

    Submitted filename: Response to Reviewer 2 12.10.21.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES